Liraglutide For Weight Loss In Non Diabetics Uk

Each pen is prefilled with 6mg ml liraglutide the same active ingredient found in other weight loss injection pens such as the skinny jab.

Liraglutide for weight loss in non diabetics uk. Liraglutide saxenda for weight loss in non diabetic obese adults. Clinical trial evidence shows that liraglutide with lifestyle measures is more effective for weight loss and delaying the development of type 2 diabetes than lifestyle measures alone. A protocol for glp 1 use in non diabetes obesity body mass index 35 kg m 2 was agreed with local clinical governance committees.

In the placebo group 29 participants 30 lost more than 5 of their weight. New research claims that the type 2 diabetes drug liraglutide can also reduce weight in obese people who do not have diabetes. Weight loss ranging from 2 to 6 kg has been a consistent finding in studies designed to investigate the glycemic benefits of incretin mimetics in individuals with type 2 diabetes.

Randomised controlled trials show efficacy in the non diabetes obese population. Weight loss with liraglutide was 2 1 kg 95 ci 0 6 3 6 to 4 4 kg 2 9 6 0 greater than the weight lost with the placebo. Thus we have audited glp 1 agonist use for weight reduction in morbidly obese people without diabetes.

The study looked at the effects of liraglutide on bodyweight in obese people without type 2 diabetes. Both groups lost approximately 6kg 6. Liraglutide victoza has been licensed in the uk for the treatment of type 2 diabetes in adults since 2009.

The research was carried out in 19 locations across europe and looked at 564 people aged 18 to 65 years with a body mass index between 30 and 40. It is only available on prescription in the uk. Liraglutide saxenda is a different licensed product to liraglutide and the doses of liraglutide saxenda used for weight management are different to that used in managing type 2 diabetes victoza.

In the group taking 3 0 mg liraglutide 70 patients 76 lost more than 5 of their weight. This study investigated the use of liraglutide 3mg in 422 non diabetic adults who had lost 5 of body weight during a run in period of 4 12 weeks using a low calorie diet. But its long term effectiveness particularly on the risk of cardiovascular disease is unknown.